Phase I study to determine the safety, tolerability and immunostimulatory activity of thalidomide analogue CC-5013 in patients with metastatic malignant melanoma and other advanced cancers.
Br J Cancer
; 90(5): 955-61, 2004 Mar 08.
Article
in En
| MEDLINE
| ID: mdl-14997189
Full text:
1
Collection:
01-internacional
Database:
MEDLINE
Main subject:
Skin Neoplasms
/
Thalidomide
/
Angiogenesis Inhibitors
/
Melanoma
Limits:
Adolescent
/
Adult
/
Aged
/
Aged80
/
Female
/
Humans
/
Male
/
Middle aged
Language:
En
Journal:
Br J Cancer
Year:
2004
Document type:
Article
Affiliation country:
United kingdom